Core Thesis
This article explores an emerging frontier in metabolic medicine: the connection between glucose instability and neurodegeneration. Dr. Abhijit Bhograj provides expert commentary on how CGM technology — traditionally used for diabetes management — could play a role in Alzheimer's prevention through early detection of insulin resistance patterns.
"Blood sugar variability, particularly in older adults, can negatively impact brain health. Continuous glucose monitoring allows us to track and manage those fluctuations more precisely."
— Dr. Abhijit Bhograj, Endocrinologist & Diabetologist, AiHealth Clinic, BangaloreThe Connection Explained
Insulin Resistance → Glucose Variability → Neuroinflammation → Cognitive Decline
Type 2 diabetes and Alzheimer's disease share a common metabolic thread: insulin dysfunction. The brain, which consumes roughly 20% of the body's glucose, is acutely sensitive to blood sugar fluctuations. Chronic variability — the repeated spikes and crashes that CGM devices can detect — triggers neuroinflammation that, over years, accelerates cognitive decline.
Dr. Bhograj highlights that CGM devices provide optional alarms when glucose levels become dangerously high or low, enabling faster corrective actions. But the real value lies in the trend data — patterns of variability that would be invisible to traditional finger-prick testing.
Key Insights
CGM Beyond Diabetes
Continuous glucose monitoring is emerging as a preventive health tool — not just for managing existing diabetes, but for identifying metabolic risk patterns before disease manifests, including neurodegenerative risk.
Variability Matters More Than Averages
An HbA1c of 6.5% can mask dangerous glucose swings. CGM reveals time-in-range, glycemic variability, and spike patterns that averaged lab values simply cannot capture — and these patterns correlate with brain health outcomes.
Early Intervention Window
The connection between insulin resistance and cognitive decline opens a window for early intervention. Detecting glucose instability in older adults through CGM may allow clinicians to intervene before irreversible neurological damage occurs.
Precision Over Protocol
Standard diabetes protocols focus on medication titration. The brain-glucose connection demands a precision approach — tracking individual variability patterns and tailoring interventions to each patient's metabolic fingerprint.